Publication date: Apr 19, 2019
Marrie, R. A. , Yu, N. , Blanchard, J. , Leung, S. Elliott, L.
The rising prevalence and changing age distribution of multiple sclerosis in Manitoba.
Finlayson, M. Concerns about the future among older adults with multiple sclerosis.
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.
Scalfari, A. , Neuhaus, A. , Daumer, M. , Muraro, P. A. Ebers, G. C. Onset of secondary progressive phase and long-term evolution of multiple sclerosis.
5. Koch-Henriksen, N. , Laursen, B. , Stenager, E. Magyari, M. Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study.
Hirst, C. , Swingler, R. , Compston, D. A. , Ben-Shlomo, Y. Robertson, N. P. Survival and cause of death in multiple sclerosis: a prospective population-based study.
Hurwitz, B. J. Analysis of current multiple sclerosis registries.
Lunde, H. M. B. , Assmus, J. , Myhr, K. M. , Bo, L. Grytten, N. Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.
Relative mortality and survival in multiple sclerosis: findings from British Columbia.
Minden, S. L. , Frankel, D. , Hadden, L. S. , Srinath, K. P. Perloff, J. N. Disability in elderly people with multiple sclerosis: an analysis of baseline data from the Sonya Slifka Longitudinal Multiple Sclerosis Study.
Temporal trends in multiple sclerosis prevalence and incidence in a large population.
Grytten, N. , Torkildsen, O. Myhr, K. M. Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.
The increasing prevalence of multiple sclerosis in New Zealand.
Multiple sclerosis prevalence in the United States commercially insured population.
The changing face of multiple sclerosis: prevalence and incidence in an aging population.
Barnett, M. H. , Williams, D. B. , Day, S. , Macaskill, P. McLeod, J. G. Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study.
Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009.
Sarasoja, T. , Wikstrom, J. , Paltamaa, J. , Hakama, M. Sumelahti, M. L. Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years.
Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000.
A systematic assessment of prevalence, incidence and regional distribution of multiple sclerosis in Bavaria from 2006 to 2015.
Multiple sclerosis incidence and prevalence trends in the province of Padua, northeast Italy, 1965-2018.
Ribbons, K. , Lea, R. , Tiedeman, C. , Mackenzie, L. Lechner-Scott, J. Ongoing increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 50-year study.
The changing demographic pattern of multiple sclerosis epidemiology.
Bermel, R. A. , Rae-Grant, A. D. Fox, R. J. Diagnosing multiple sclerosis at a later age: more than just progressive myelopathy.
Poser, C. M. Brinar, V. V. Diagnostic criteria for multiple sclerosis: an historical review.
The diagnostic criteria for multiple sclerosis: from Charcot to McDonald.
Polliack, M. L. , Barak, Y. Achiron, A. Late-onset multiple sclerosis.
Delalande, S. , De Seze, J. , Ferriby, D. , Stojkovic, T. Vermersch, P. Late onset multiple sclerosis [French].
Tremlett, H. Devonshire, V. Is late-onset multiple sclerosis associated with a worse outcome?
Hooge, J. P. Redekop, W. K. Multiple sclerosis with very late onset.
31. Koch-Henriksen, N. , Thygesen, L. C. , Stenager, E. , Laursen, B. Magyari, M. Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women.
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.
Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: an observational study using the US Department of Defense administrative claims database.
Manouchehrinia, A. , Tanasescu, R. , Tench, C. R. Constantinescu, C. S. Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.
Mortality in patients with multiple sclerosis.
Survival in commercially insured multiple sclerosis patients and comparator subjects in the U. S. Mult.
38. Bronnum-Hansen, H. , Koch-Henriksen, N. Stenager, E. Trends in survival and cause of death in Danish patients with multiple sclerosis.
Ragonese, P. , Aridon, P. , Salemi, G. , D’Amelio, M. Savettieri, G. Mortality in multiple sclerosis: a review.
Warren, S. A. , Janzen, W. , Warren, K. G. , Svenson, L. W. Schopflocher, D. P. Multiple sclerosis mortality rates in Canada, 1975-2009.
Amezcua, L. , Rivas, E. , Joseph, S. , Zhang, J. Liu, L. Multiple sclerosis mortality by race/ethnicity, age, sex, and time period in the United States, 1999-2015.
Hemmer, B. , Kerschensteiner, M. Korn, T. Role of the innate and adaptive immune responses in the course of multiple sclerosis.
The immune pathogenesis of multiple sclerosis.
An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis.
Fletcher, J. M. , Lalor, S. J. , Sweeney, C. M. , Tubridy, N. Mills, K. H. G. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
A B cell-driven autoimmune pathway leading to pathological hallmarks of progressive multiple sclerosis in the marmoset experimental autoimmune encephalomyelitis model.
Reich, D. S. , Lucchinetti, C. F. Calabresi, P. A. Multiple sclerosis.
Gandhi, R. , Laroni, A. Weiner, H. L. Role of the innate immune system in the pathogenesis of multiple sclerosis.
Kasper, L. H. Shoemaker, J. Multiple sclerosis immunology: the healthy immune system versus the MS immune system.
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.
Lassmann, H. , van Horssen, J. Mahad, D. Progressive multiple sclerosis: pathology and pathogenesis.
Stephenson, E. , Nathoo, N. , Mahjoub, Y. , Dunn, J. F. Yong, V. W. Iron in multiple sclerosis: roles in neurodegeneration and repair.
Grebenciucova, E. Berger, J. R. Immunosenescence: the role of aging in the predisposition to neuro-infectious complications arising from the treatment of multiple sclerosis.
Lassmann, H. Pathology and disease mechanisms in different stages of multiple sclerosis.
Aging and multiple sclerosis.
Elevated ATG5 expression in autoimmune demyelination and multiple sclerosis.
Peterson, J. W. Trapp, B. D. Neuropathobiology of multiple sclerosis.
Dutta, R. Trapp, B. D. Relapsing and progressive forms of multiple sc